Telix Pharmaceuticals Ltd
Illuccix
prostate cancer imaging
Resolved
509days ago
Approval decision · Feb 13, 2025
What's at stake
A final FDA approval decision on Illuccix for prostate cancer imaging is expected Feb 13, 2025.
Primary source
· SEC 6-K
verified 12h ago
“Telix ASX disclosure 13 February 2025.”